ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 36 | +3500.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q3 2018 | $873,000 | -13.4% | 226,844 | -24.0% | 0.00% | – |
Q2 2018 | $1,008,000 | +1801.9% | 298,644 | +1094.6% | 0.00% | – |
Q1 2018 | $53,000 | -98.0% | 25,000 | -97.1% | 0.00% | – |
Q1 2016 | $2,671,000 | -29.9% | 867,314 | -12.4% | 0.00% | -100.0% |
Q4 2015 | $3,812,000 | +25.2% | 990,014 | -0.8% | 0.00% | – |
Q3 2015 | $3,045,000 | -31.0% | 998,314 | -4.0% | 0.00% | -100.0% |
Q2 2015 | $4,410,000 | -33.8% | 1,040,114 | -39.7% | 0.00% | 0.0% |
Q1 2015 | $6,659,000 | +1.8% | 1,725,253 | +77.6% | 0.00% | 0.0% |
Q4 2014 | $6,539,000 | +79.6% | 971,601 | +46.5% | 0.00% | – |
Q3 2014 | $3,641,000 | -46.4% | 663,239 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $6,798,000 | -19.9% | 663,239 | -6.2% | 0.00% | 0.0% |
Q1 2014 | $8,492,000 | +6.2% | 707,039 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $7,997,000 | -8.5% | 707,039 | -12.8% | 0.00% | 0.0% |
Q3 2013 | $8,736,000 | +6.1% | 811,139 | -8.7% | 0.00% | 0.0% |
Q2 2013 | $8,232,000 | – | 888,039 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |